Summary score
8%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HGEN | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 17.45% | 19.89% | 0% |
| Return on assets | 0% | 3.37% | 11.41% | 0% |
| Return on sales | 0% | 23.96% | 42.05% | 0% |
| Return on invested capital | 0% | 5.2% | -272.99% | 0% |
| Profitability | 0% | 69% | 75% | 0% |
| Total debt ratio | 0% | 77% | 53.92% | 0% |
| Debt ratio change over time | 0% | 0.36% | -1.16% | 0% |
| Dept financing | 0% | 50% | 18% | 0% |
| Current Ratio | 0% | 1.16% | 1.05% | 0% |
| Quick Ratio | 0% | 0.89% | 0.77% | 0% |
| Cash Position Ratio | 0% | 0.17% | 0.31% | 0% |
| Liquididy | 0% | 75% | 65% | 0% |
| Short-term ratios | HGEN | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 44.06% | 17.3% | 0% |
| Return on assets | 0% | 3.88% | 9.33% | 0% |
| Return on sales | 0% | 27.04% | 40.02% | 0% |
| Return on invested capital | 0% | 9.69% | -224.06% | 0% |
| Profitability | 0% | 77% | 60% | 0% |
| Total debt ratio | 0% | 91.8% | 55.88% | 0% |
| Debt ratio change over time | 0% | 8.35% | -0.88% | 0% |
| Dept financing | 0% | 50% | 15% | 0% |
| Current Ratio | 0% | 1.16% | 1.05% | 0% |
| Quick Ratio | 0% | 0.89% | 0.77% | 0% |
| Cash Position Ratio | 0% | 0.17% | 0.31% | 0% |
| Liquididy | 0% | 64% | 69% | 0% |